Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AddLife AB ( ($SE:ALIF.B) ) just unveiled an update.
AddLife AB’s Annual General Meeting approved the company and group financial statements, granted discharge from liability to the board and CEOs, and declared a dividend of SEK 1.50 per share with payment in mid-May. Shareholders re-elected five directors, appointed Fredrik Rågmark as a new board member, confirmed Johan Sjö as chairman, set increased board and committee fees, and reappointed Öhrlings PricewaterhouseCoopers AB with a new auditor in charge.
The AGM adopted a new long-term incentive programme for up to 17 senior executives based on performance shares, including the transfer of up to 150,500 treasury shares to participants. The board also received mandates to repurchase and transfer class B shares and to issue new shares of up to 10 percent of the company’s share capital, providing flexibility to adjust capital structure, finance future acquisitions, and meet obligations under the incentive scheme.
More about AddLife AB
AddLife AB is a Stockholm-based company active in the life science sector, focusing on medical technology and laboratory products. The group serves healthcare and research customers, and actively uses acquisitions and capital markets tools to support its growth strategy and strengthen its financial position.
Average Trading Volume: 170,922
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.4B
For detailed information about ALIF.B stock, go to TipRanks’ Stock Analysis page.